20. November 2009 09:28
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
[More]
9de2aaf9-d1dc-42a8-8d75-d56e72072c7e|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Biotechnology, Cancer, Cell, Chemotherapy, Glioma, Kidney Cancer, Lymphoma, Melanoma, Oncology, Renal Cell Carcinoma, Vaccine
20. November 2009 07:45
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.
[More]
25d5bf3a-1a13-4ddf-befb-b2fa1aaa7721|0|.0
Posted in: Device / Technology News | Pharmaceutical News
Tags: Allergy, Anthrax, Beclomethasone, Biotechnology, Cancer, Cell, Corticosteroid, Drug Delivery, Endometriosis, Prostate Cancer, Vaccine
20. November 2009 06:39
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
[More]
5ea790c2-653b-41a5-a70d-b25aa6cc161b|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Antibody, Avian Influenza, Cancer, Cervical Cancer, DNA, Gene Expression, H1N1, H3N2, H5N1, Influenza, Pandemic, Swine Flu, Vaccine, Virus
20. November 2009 04:38
Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).
[More]
20. November 2009 04:19
Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members.
[More]
20. November 2009 04:04
Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Market Trends" report to their offering.
[More]
20. November 2009 02:59
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
[More]
20. November 2009 02:34
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense (www.sciencedirect.com/science/journal/0264410X).
[More]
20. November 2009 00:30
A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites.
[More]
20. November 2009 00:16
A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. While much research has been conducted on insulin since its discovery in the 1920s, this is the first time the hormone has been connected to the fundamental process of temperature regulation.
[More]
8ab6b755-b25b-4761-a40b-16eba752d9c0|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Brain, Brown Fat, Cell, Cellular Biology, Diabetes, Hypothermia, Immunology, Insulin, Metabolism, Obesity, Pfizer, Sleep, Vaccine, Weight Loss
19. November 2009 11:35
HIV/AIDS program grants made by U.S.-based foundations totaled $618 billion in 2008, an 11 percent increase from the previous year, according to a new report by Funders Concerned About AIDS, the Chronicle of Philanthropy reports. The Bill & Melinda Gates Foundation accounted for the majority of the grants, and when it was "excluded, foundation giving [for HIV/AIDS] actually declined 3 percent compared to 2007."
[More]
19. November 2009 08:11
Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat (GRN163L), a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
[More]
19. November 2009 07:30
Public health officials walking a tightrope between massive demand for vaccines and intense public scrutiny of side effects now have a new standard for evaluating the safety of their vaccination programs.
[More]
19. November 2009 06:22
The Washington Global Health Alliance, a group representing 26 life-sciences businesses, institutions and governmental organizations, has completed an internal coordination study demonstrating the significant influence of its primary partners in the mission of global health.
[More]
19. November 2009 06:14
The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community.
[More] 
Subscribe